Nutranomics, Inc. (OTCBB:NNRX) Pushed Further by Pumpers
Even a choppy-looking graph will have its enticing smooth periods. It looks like Nutranomics, Inc. (OTCBB:NNRX) has decided to move in a certain direction in the past days. On Tuesday, the ticker added more than 18% to $0.62, on dollar volumes above $1.48 million. 
No wonder NNRX is active, since it is picked up for free by a series of promoters, as a way to boost results for pumpers. NNRX is a higher-tier penny stock that holds promise in the field of pharmaceutical research. The company is surrounded by enough PR messages, just like many pharmaceutical businesses, and relies a lot in making a good impression with future promises. Adding a new email coming in on Tuesday, this explains rather well the double-digit percentage climb.
While NNRX holds a respectable price range, its sudden appearance with a new name is a classic red flag. NNRX, formerly known as Buka Ventures, Inc., is even listed as a dairy products company, and now it strangely switched to investigating the potential for cancer therapies. For this, the company is equipped with:
- $1,439 cash
- $3,939 total current assets
- $2,539 total current liabilities
- ZERO revenues
- $3,680 net loss
Even for an OTCBB pharmaceutical company, those numbers are quite low. Research companies measure in the millions, and risk the burden of long years of development before a drug comes to market. The low results come in despite claims that NNRX is an established seller of food supplements. The company also claims sales to Asian countries, as well as licensing its technologies to other producers.
In a way, the graph for NNRX recalls that of Biozone Pharmaceuticals, Inc. (OTCBB:BZNE), which also came in from general obscurity and started trading more actively after the inclusion of a key investor, Dr. Phillip Frost.
And not even Titan Pharmaceuticals, Inc. (OTCBB:TTNP) has enough power to chart a better graph. Instead of a smooth recovery, TTNP attacks the dollar levels through choppy, erratic movements.
If you still like NNRX, keep in mind that the ticker may start to take off, but almost all of the movement is fueled by PR, and now by the newest email from Penny Stocks Forever. Avoid investing, if you cannot afford the cuts that NNRX has endured in the past.
